Cargando…

Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer()()

Anthracyclines, such as doxorubicin, are used as first-line chemotherapeutics, usually in combination therapies, for the treatment of advanced breast cancer. While these drugs have been successful therapeutic options, their use is limited due to serious drug related toxicities and acquired tumor res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasim, Mohamed S., Nessim, Carolyn, Villeneuve, Patrick J., Vanderhyden, Barbara C., Dimitroulakos, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039300/ https://www.ncbi.nlm.nih.gov/pubmed/29940414 http://dx.doi.org/10.1016/j.tranon.2018.06.001

Ejemplares similares

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells()()
por: Bar, Jair, et al.
Publicado: (2016)

Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
por: St Germain, Carly, et al.
Publicado: (2010)

Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer
por: Howe, Grant A., et al.
Publicado: (2016)

Context specificity of the EMT transcriptional response
por: Cook, David P., et al.
Publicado: (2020)

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
por: Sulaiman, Andrew, et al.
Publicado: (2018)

Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers
por: Schlosser, Kenny, et al.
Publicado: (2016)

Transcriptional census of epithelial-mesenchymal plasticity in cancer
por: Cook, David P., et al.
Publicado: (2022)

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
por: Sulaiman, Andrew, et al.
Publicado: (2018)

Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
por: Ma, Laurie, et al.
Publicado: (2012)

Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer
por: Topouza, Danai G., et al.
Publicado: (2022)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Retroperitoneal Sarcoma Care in 2021
por: Schmitz, Erika, et al.
Publicado: (2022)

The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells
por: Weberpals, Johanne I, et al.
Publicado: (2011)

Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth
por: Thomas, Fiona H, et al.
Publicado: (2006)

Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells
por: Robichaud, Sabrina, et al.
Publicado: (2021)

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Prioritizing Melanoma Surgeries to Prevent Wait Time Delays and Upstaging of Melanoma during the COVID-19 Pandemic
por: Aw, Katherine, et al.
Publicado: (2023)

A 3-gene biomarker signature to predict response to taxane-based neoadjuvant chemotherapy in breast cancer
por: Kallarackal, Jim, et al.
Publicado: (2020)

miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels
por: Honeywell, D. Rice, et al.
Publicado: (2013)

ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform
por: Klec, Christiane, et al.
Publicado: (2022)

Transcriptional Regulation of the Beta-Synuclein 5′-Promoter Metal Response Element by Metal Transcription Factor-1
por: McHugh, Patrick C., et al.
Publicado: (2011)

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Fujiki, Yoshitaka, et al.
Publicado: (2018)

Transcriptional and Post-Transcriptional Regulation of Proangiogenic Factors by the Unfolded Protein Response
por: Pereira, Ethel R., et al.
Publicado: (2010)

Transcriptional regulation of drought response: a tortuous network of transcriptional factors
por: Singh, Dhriti, et al.
Publicado: (2015)

Targeting TBP-Associated Factors in Ovarian Cancer
por: Ribeiro, Jennifer R., et al.
Publicado: (2014)

Role of a skin bridge incision and prophylactic incisional negative-pressure wound therapy in the prevention of surgical site infection after inguinal lymph node dissection
por: Frenda, Giuseppe, et al.
Publicado: (2022)

Novel peripheral blood parameters as predictors of neoadjuvant chemotherapy response in breast cancer
por: Yang, Gaohua, et al.
Publicado: (2022)

Fibrinogen-Like Protein 2-Associated Transcriptional and Histopathological Features of Immunological Preeclampsia
por: Robineau-Charette, Pascale, et al.
Publicado: (2020)

Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium
por: Abedini, Atefeh, et al.
Publicado: (2020)

Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study
por: Quimby, Alexandra E., et al.
Publicado: (2018)

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling
por: Al-Zahrani, Khalid N., et al.
Publicado: (2018)

Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma
por: Whitaker, John, et al.
Publicado: (2023)

Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Yoon Yang, et al.
Publicado: (2016)

Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer
por: Liu, Junhao, et al.
Publicado: (2021)

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach
por: Díaz, Caridad, et al.
Publicado: (2022)

The novel transcriptional factor HP1BP3 negatively regulates Hsp70 transcription in Crassostrea hongkongensis
por: Xu, Delin, et al.
Publicado: (2017)

Post-Transcriptional Regulation of Cadherin-11 Expression by GSK-3 and β-Catenin in Prostate and Breast Cancer Cells
por: Farina, Anne K., et al.
Publicado: (2009)

Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women
por: Hasim, Ayshamgul, et al.
Publicado: (2012)

Correction to: HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
por: Wasserman, Jason K., et al.
Publicado: (2018)

Regulation of the apoptotic genes in breast cancer cells by the transcription factor CTCF
por: Mendez-Catala, CF, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u0h8nad57pc8uu5p71q897m9pf